Biotech Distilled
133 companies · 839 active programs
Substack ↗
Subscribe
Therapeutic Areas
Modalities
Phases
Targets
Companies
Home
›
Targets
› α4β7 integrin
α4β7 integrin
(1 companies · 2 programs)
Companies with an active program directed at α4β7 integrin.
Spyre Therapeutics, Inc.
SYRE
SPY001
— Ulcerative Colitis
Phase 2
SPY001
— Crohn's Disease
Phase 2